A 42-year-old woman presents with 6 months of early morning joint stiffness lasting over an hour, symmetrical swelling of the MCP and PIP joints and raised inflammatory markers. Anti-CCP antibodies are positive. According to NICE rheumatoid arthritis guidance, what is the most appropriate initial disease-modifying treatment strategy?